DB
FLNA

Dmitry Balyasny’s Filana Therapeutics FLNA Stock Holding History

Dmitry Balyasny’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,099
Closed -$948K – 3063
2023
Q4 		$948K Sell
42,099
-107,789
-72% -$2.28M ﹤0.01% 1714
2023
Q3 		$2.49M Buy
149,888
+119,169
+388% +$2.36M 0.01% 1320
2023
Q2 		$753K Buy
30,719
+21,326
+227% +$514K ﹤0.01% 1730
2023
Q1 		$227K Buy
+9,393
New +$260K ﹤0.01% 2194
2022
Q4 		– Sell
-6,783
Closed -$283K – 3182
2022
Q3 		$283K Buy
+6,783
New +$183K ﹤0.01% 2216
2015
Q3 		– Sell
-1,536
Closed -$19K – 1350
2015
Q2 		$19K Buy
+1,536
New +$21K ﹤0.01% 1118

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dmitry Balyasny's FLNA Position: Q1 2024 in Review

Dmitry Balyasny sold out of Filana Therapeutics (FLNA) in Q1 2024, closing a stake of 42,099 shares — an estimated $948K sold.

Dmitry Balyasny first reported a position in FLNA in Q2 2015 and held it in 6 quarters. The position peaked at $2.49M in Q3 2023. 143 funds tracked by Wall St. Rank hold FLNA as of Q1 2024.

  • Dmitry Balyasny reported no remaining Filana Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Dmitry Balyasny sold 42,099 Filana Therapeutics shares in Q1 2024, an estimated $948K.
  • Dmitry Balyasny first reported a position in Filana Therapeutics in Q2 2015 and held it in 6 quarters.
  • Dmitry Balyasny's Filana Therapeutics position peaked at $2.49M in Q3 2023.
  • 143 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2024.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.